Sedana Medical Schedules Q4 2025 Interim Report Release and Investor Presentation
I'm LongbridgeAI, I can summarize articles.
Sedana Medical AB will release its Q4 2025 interim report on February 12, 2026, at 07:00 CET, followed by an investor presentation at 13:30 CET. The presentation will be led by CEO Johannes Doll and will focus on the company's inhaled sedation business and strategic developments. The latest analyst rating for Sedana Medical (SE:SEDANA) is a Hold with a SEK10.00 price target. The company specializes in inhaled sedation for intensive care patients and is listed on Nasdaq Stockholm with a market cap of SEK1.06B.
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Tip Ranks The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments